Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Tumori|February 28, 1989
CA 125 reliability in predicting ovarian cancer recurrenceF Zanaboni, M Presti, G Scarfone, et al.
Seminars in Oncology|February 1, 1997
A phase I trial with fixed-dose carboplatin and escalating doses of paclitaxel in advanced ovarian cancerG Bolis, G Scarfone, A Villa, et al.
Tumori|December 10, 1999
A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapyG Scarfone, A Villa, F Parazzini, et al.
Gynecologic Oncology|January 4, 2001
Response and toxicity to topotecan in sensitive ovarian cancer cases with small residual disease after first-line treatment with carboplatinum and paclitaxelG Bolis, G Scarfone, S Tateo, et al.
Gynecologic Oncology|October 1, 1991
Salvage chemotherapy for ovarian cancer recurrence: weekly cisplatin in combination with epirubicin or etoposideF Zanaboni, G Scarfone, M Presti, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 26, 2000
Site of origin of epithelial ovarian cancer: the endometriosis connectionP Vercellini, G Scarfone, G Bolis, et al.
Gynecologic Oncology|November 1, 1990
The impact of whole-abdomen radiotherapy on survival in advanced ovarian cancer patients with minimal residual disease after chemotherapyG Bolis, F Zanaboni, P Vanoli, et al.
European Journal of Gynaecological Oncology|January 19, 2013
Ten years survival of FIGO stage IIIC epithelial ovarian cancer cases due to lymph node metastases onlyE Grossi, S Noli, G Scarfone, et al.
Radiology|September 1, 1993
Carcinoma of the cervix: value of plain and gadolinium-enhanced MR imaging in assessing degree of invasivenessS Sironi, F De Cobelli, G Scarfone, et al.
Gynecologic Oncology|December 6, 2001
A phase I/II study of topotecan in combination with carboplatin in recurrent epithelial ovarian cancerG Bolis, G Scarfone, C Sciatta, et al.
Pageof 11